Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sleight

Showing results (41-50 of 290) with videos related to

Pageof 29
Sort By:
Current Cardiology Reports|October 17, 2001
The role of angiotensin-converting enzyme inhibitors in the treatment of hypertensionP Sleight
Hypertension (Dallas, Tex. : 1979)|September 1, 1983
When and how far should we lower blood pressure?P Sleight
Chest|February 1, 1983
The influence of arterial baroreceptors in man on the variability of blood pressure and plasma catecholamines in manP Sleight
The American Journal of Cardiology|December 16, 1993
Is there an age limit for thrombolytic therapy?P Sleight
European Heart Journal|July 1, 1995
Are antianginal drugs effective in post-myocardial infarction secondary prevention?P Sleight
Blood Pressure|July 1, 1996
Short term and long term effects of alcohol on blood pressure, cardiovascular risk and all cause mortalityP Sleight
Circulation|May 1, 1990
Do we need to intervene after thrombolysis in acute myocardial infarction?P Sleight
Journal of Cardiovascular Pharmacology|January 1, 1994
Cardiac benefits of ACE inhibitors and calcium antagonists alone and in combinationP Sleight
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1993
Is cardioprotection important in the treatment of hypertension? Considerations for the ideal agentP Sleight
Postgraduate Medical Journal|January 1, 1983
Interventions during and after acute myocardial infarctionP Sleight
Pageof 29

Showing results (41-50 of 290) with videos related to

Sort By:
Pageof 29
Current Cardiology Reports|October 17, 2001
The role of angiotensin-converting enzyme inhibitors in the treatment of hypertensionP Sleight
Hypertension (Dallas, Tex. : 1979)|September 1, 1983
When and how far should we lower blood pressure?P Sleight
Chest|February 1, 1983
The influence of arterial baroreceptors in man on the variability of blood pressure and plasma catecholamines in manP Sleight
The American Journal of Cardiology|December 16, 1993
Is there an age limit for thrombolytic therapy?P Sleight
European Heart Journal|July 1, 1995
Are antianginal drugs effective in post-myocardial infarction secondary prevention?P Sleight
Blood Pressure|July 1, 1996
Short term and long term effects of alcohol on blood pressure, cardiovascular risk and all cause mortalityP Sleight
Circulation|May 1, 1990
Do we need to intervene after thrombolysis in acute myocardial infarction?P Sleight
Journal of Cardiovascular Pharmacology|January 1, 1994
Cardiac benefits of ACE inhibitors and calcium antagonists alone and in combinationP Sleight
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1993
Is cardioprotection important in the treatment of hypertension? Considerations for the ideal agentP Sleight
Postgraduate Medical Journal|January 1, 1983
Interventions during and after acute myocardial infarctionP Sleight
Pageof 29